Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Kleenex maker's deal for troubled Johnson & Johnson spinoff comes amid lawsuits and regulatory scrutiny

Kleenex and Huggies maker Kimberly-Clark unveiled plans to buy Kenvue, the embattled consumer health conglomerate behind Tylenol, in a landmark deal for more than $40bn.

The blockbuster takeover comes weeks after Donald Trump claimed Tylenol heightens the risk of autism in children when it is used by pregnant women, an assertion hotly contested by scientists and contradicted by studies.